247 related articles for article (PubMed ID: 32060729)
1. Targeting BK
Al-Karagholi MA; Gram C; Nielsen CAW; Ashina M
CNS Drugs; 2020 Apr; 34(4):325-335. PubMed ID: 32060729
[TBL] [Abstract][Full Text] [Related]
2. The role of high-conductance calcium-activated potassium channel in headache and migraine pathophysiology.
Al-Karagholi MA; Hakbilen CC; Ashina M
Basic Clin Pharmacol Toxicol; 2022 Nov; 131(5):347-354. PubMed ID: 36028922
[TBL] [Abstract][Full Text] [Related]
3. Hypersensitivity to BK
Al-Khazali HM; Christensen RH; Dodick DW; Chaudhry BA; Melchior AG; Burstein R; Ashina H
J Headache Pain; 2024 Jun; 25(1):102. PubMed ID: 38890563
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Potassium Channel Signalling in Migraine Pathophysiology.
Al-Karagholi MA
Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986537
[TBL] [Abstract][Full Text] [Related]
5. Large conductance calcium-activated potassium channels (BKCa) modulate trigeminovascular nociceptive transmission.
Storer RJ; Immke DC; Goadsby PJ
Cephalalgia; 2009 Dec; 29(12):1242-58. PubMed ID: 19911462
[TBL] [Abstract][Full Text] [Related]
6. Opening of BK
Al-Karagholi MA; Ghanizada H; Nielsen CAW; Skandarioon C; Snellman J; Lopez Lopez C; Hansen JM; Ashina M
Cephalalgia; 2020 Oct; 40(11):1145-1154. PubMed ID: 32847403
[TBL] [Abstract][Full Text] [Related]
7. The K
Al-Karagholi MA; Hansen JM; Severinsen J; Jansen-Olesen I; Ashina M
J Headache Pain; 2017 Aug; 18(1):90. PubMed ID: 28831746
[TBL] [Abstract][Full Text] [Related]
8. ATP sensitive potassium (K
Christensen SL; Munro G; Petersen S; Shabir A; Jansen-Olesen I; Kristensen DM; Olesen J
Cephalalgia; 2020 Jun; 40(7):650-664. PubMed ID: 32418458
[TBL] [Abstract][Full Text] [Related]
9. Future targets for migraine treatment beyond CGRP.
Al-Hassany L; Boucherie DM; Creeney H; van Drie RWA; Farham F; Favaretto S; Gollion C; Grangeon L; Lyons H; Marschollek K; Onan D; Pensato U; Stanyer E; Waliszewska-Prosół M; Wiels W; Chen HZ; Amin FM;
J Headache Pain; 2023 Jun; 24(1):76. PubMed ID: 37370051
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets.
Haanes KA; Edvinsson L
CNS Drugs; 2019 Jun; 33(6):525-537. PubMed ID: 30989485
[TBL] [Abstract][Full Text] [Related]
11. Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat.
Gozalov A; Jansen-Olesen I; Klaerke D; Olesen J
Headache; 2008 Sep; 48(8):1202-13. PubMed ID: 18647185
[TBL] [Abstract][Full Text] [Related]
12. Expression of Pituitary Adenylate Cyclase-activating Peptide, Calcitonin Gene-related Peptide and Headache Targets in the Trigeminal Ganglia of Rats and Humans.
Frederiksen SD; Warfvinge K; Ohlsson L; Edvinsson L
Neuroscience; 2018 Nov; 393():319-332. PubMed ID: 30336190
[TBL] [Abstract][Full Text] [Related]
13. Underlying mechanisms preserving coronary basal tone and NO-mediated relaxation in obesity: Involvement of β1 subunit-mediated upregulation of BK
Climent B; Sánchez A; Moreno L; Pérez-Vizcaíno F; García-Sacristán A; Rivera L; Prieto D
Atherosclerosis; 2017 Aug; 263():227-236. PubMed ID: 28672269
[TBL] [Abstract][Full Text] [Related]
14. Migraine Treatment: Towards New Pharmacological Targets.
Silvestro M; Iannone LF; Orologio I; Tessitore A; Tedeschi G; Geppetti P; Russo A
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569648
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of BK
Patel NH; Johannesen J; Shah K; Goswami SK; Patel NJ; Ponnalagu D; Kohut AR; Singh H
Physiol Rep; 2018 Jun; 6(12):e13748. PubMed ID: 29932499
[TBL] [Abstract][Full Text] [Related]
16. Real world considerations for newly approved CGRP receptor antagonists in migraine care.
Scuteri D; Tonin P; Nicotera P; Bagetta G; Corasaniti MT
Expert Rev Neurother; 2022 Mar; 22(3):221-230. PubMed ID: 35240905
[TBL] [Abstract][Full Text] [Related]
17. Potassium channel openers as potential therapeutic weapons in ion channel disease.
Lawson K
Kidney Int; 2000 Mar; 57(3):838-45. PubMed ID: 10720937
[TBL] [Abstract][Full Text] [Related]
18. Calcium-activated BK
Sun X; Hirano AA; Brecha NC; Barnes S
J Physiol; 2017 Jul; 595(13):4449-4465. PubMed ID: 28374528
[TBL] [Abstract][Full Text] [Related]
19. K(ATP) channel openers in the trigeminovascular system.
Ploug KB; Amrutkar DV; Baun M; Ramachandran R; Iversen A; Lund TM; Gupta S; Hay-Schmidt A; Olesen J; Jansen-Olesen I
Cephalalgia; 2012 Jan; 32(1):55-65. PubMed ID: 22144717
[TBL] [Abstract][Full Text] [Related]
20. Opening of BKCa channels causes migraine attacks: a new downstream target for the treatment of migraine.
Al-Karagholi MA; Ghanizada H; Waldorff Nielsen CA; Skandarioon C; Snellman J; Lopez-Lopez C; Hansen JM; Ashina M
Pain; 2021 Oct; 162(10):2512-2520. PubMed ID: 34252916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
